[카테고리:] 뉴스 (News)

In an interview with Seoul Economic Daily, Changwon Keum, CEO of the genetic analysis technology startup 3billion said, “As AI can increase the efficiency of identifying rare diseases necessary for doctors’ final diagnoses, the demand for AI genetic diagnosis will increase.” Traditionally, it takes 20 to 40 hours for a doctor to interpret genetic variations…

In the 6th CAGI(Critical Assessment of Genome Interpretation) Challenges, a global artificial intelligence genomic interpretation contest, 3billion took first place by predicting the rare diseases of 79 patients within the data of The Hospital for Sick Children in Canada. 3billion’s AI model recorded 58%, showing a 16%p gap from the 2nd group with a score of 42%,…

3billion released a company video explaining why rare disease is so difficult to diagnose and how 3billion is solving them. Check out the video and learn about 3billion and its solutions.

3billion has announced Dr. Hane Lee, a former UCLA professor of pathology/diagnostic medicine and human genetics, as ‘Chief Clinical Geneticist and Director of Clinical Genetic Laboratory’ overseeing the R&D for genetic diagnosis process to advance the interpretation of genetic mutation in rare diseases. Dr. Lee had been a professor at UCLA since 2011. Dr. Lee…

3billion attended the International Conference of Pediatric Neurology (ICPN 2023) held at the Tolip Golden Plaza Hotel in Egypt last May. Hosted by the Egyptian Specialized Society of Pediatric Neurology and Neurodisability (ESSPNN), the conference was attended by pediatric neurologists, geneticists, and related companies. 3billion actively engaged with existing customers such as Ain Shams University,…

Last January, Changwon Keum, the CEO of 3billion,3billion promoted its 3billion’s testing service “3B-GENOME”, and presented clinical cases at the annual meeting of the American College of Medical Geneticists (ACMG) in Salt Lake City, Utah, USA from March 14th to 18th.  We had the opportunity to meet with various healthcare professionals and researchers at this event,…

3billion is participating in the annual meeting of the American College of Medical Geneticists (ACMG) in Salt Lake City, Utah, USA from March 14th to 18th. At the ACMG annual meeting, 3billion will promote its testing service “3B-GENOME“, based on whole genome sequencing, and the underlying technology. In contrast to conventional panel testing and whole…

3billion, an AI-based rare genetic disease diagnostic company, is showcasing its new services at the American College of Medical Genetics and Genomics (ACMG) annual meeting held in Toronto, Canada from March 13 to 15. The ACMG (American College of Medical Genetics and Genomics) holds its annual conference to establish global genetic diagnostic standards and guidelines,…

3billion people participated in Medlab Asia 2023, held in Bangkok, Thailand, from August 16th to 18th. The site attracted approximately 200 business officials, distributors, and hospital officials from various countries in Asia, fostering extensive communication and engagement. We will continue communicating with them and trying to find partners to distribute our products.

3billion participated in the Medlab 2023 Middle East, held in Dubai, UAE. The exhibition was held for four days, from February 6th to 9th. This was the first commercial exhibition for 3billion in three years, since Medlab ME 2020. 3billion received a lot of attention on-site for its exhibition, which included graphics that conveyed the…